Poniard Pharmaceuticals, Inc. (PARD)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST
Poniard Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | 2005 - 2001 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '11 Sep 30, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | 2005 - 2001 |
| Selling, General & Admin | 14.44 | 18.43 | 16.6 | 16.91 | 14.43 | 8.51 | Upgrade
|
| Research & Development | -0.12 | 6.69 | 24.34 | 32.25 | 21.03 | 12.4 | Upgrade
|
| Operating Expenses | 14.32 | 25.12 | 40.94 | 49.16 | 35.46 | 20.9 | Upgrade
|
| Operating Income | -14.32 | -25.12 | -40.94 | -49.16 | -35.46 | -20.9 | Upgrade
|
| Interest Expense | -0.54 | -2.21 | -3.14 | -1.9 | -1.73 | - | Upgrade
|
| Interest & Investment Income | 0.01 | 0.12 | 0.41 | 2.49 | 4.3 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | - | - | - | - | -2.06 | Upgrade
|
| EBT Excluding Unusual Items | -14.83 | -27.21 | -43.67 | -48.57 | -32.89 | -22.96 | Upgrade
|
| Merger & Restructuring Charges | - | -1.63 | -0.47 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.01 | - | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.11 | 0.07 | Upgrade
|
| Asset Writedown | - | - | -2.07 | - | - | -0.4 | Upgrade
|
| Other Unusual Items | -1.22 | -1.22 | 0.5 | - | - | - | Upgrade
|
| Pretax Income | -16.04 | -30.05 | -45.72 | -48.57 | -32.78 | -23.29 | Upgrade
|
| Earnings From Continuing Operations | -16.04 | -30.05 | -45.72 | -48.57 | -32.78 | -23.29 | Upgrade
|
| Net Income | -16.04 | -30.05 | -45.72 | -48.57 | -32.78 | -23.29 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.19 | 0.74 | 0.5 | 0.5 | 0.5 | 0.5 | Upgrade
|
| Net Income to Common | -16.23 | -30.79 | -46.22 | -49.07 | -33.28 | -23.79 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 289.32% | 368.30% | 1.69% | 12.76% | 77.04% | 209.68% | Upgrade
|
| EPS (Basic) | -3.79 | -7.46 | -52.41 | -56.58 | -43.28 | -54.77 | Upgrade
|
| EPS (Diluted) | -3.79 | -7.46 | -52.41 | -56.58 | -43.28 | -54.77 | Upgrade
|
| Free Cash Flow | -10.47 | -24.28 | -35.51 | -33.88 | -25.43 | -17.66 | Upgrade
|
| Free Cash Flow Per Share | -2.44 | -5.88 | -40.27 | -39.07 | -33.06 | -40.65 | Upgrade
|
| EBITDA | -13.04 | -23.8 | -39.47 | -47.55 | -33.93 | -20.3 | Upgrade
|
| D&A For EBITDA | 1.28 | 1.31 | 1.47 | 1.6 | 1.53 | 0.61 | Upgrade
|
| EBIT | -14.32 | -25.12 | -40.94 | -49.16 | -35.46 | -20.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.